Nodus Oncology
PrivateLast Round
Seed
Jan 11, 2024
Total Funding Raised
$5.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nodus Oncology is a biotechnology company that develops small molecule therapeutics targeting DNA damage response pathways for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nodus Oncology Comparables
Compare Nodus Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azkarra Therapeutics | 86% | |
| FoRx Therapeutics | 86% | |
| Artios Pharma | 82% | |
Nodus Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 11, 2024 | ||||
| Seed | Feb 7, 2023 | ||||
| Seed | Sep 6, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 57% MoM.
- Jan 19, 2026
Monthly visitors increased 44% MoM.
Nodus Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nodus Oncology's valuation, stock price, and market status.